Compare Recursion Pharmaceuticals Inc (RXRX) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Zillow Group Inc Class C — how do they compare? Recursion Pharmaceuticals Inc trades at $3.36 (market cap $1.81B), while Zillow Group Inc Class C trades at $34.1 (market cap $7.68B). The key difference: Zillow Group Inc Class C is far larger — about 4.2× Recursion Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| RXRX | Z | |
|---|---|---|
Market Cap | $1.81B | $7.68B |
Sector | Health | Media |
52-Week High | $6.79 | $90.35 |
52-Week Low | $2.84 | $29.41 |
Enterprise Value | $1.33B | $7.56B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
